Drug Profile
Breast cancer vaccine - AVAX Technologies
Alternative Names: B-VaxLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Thomas Jefferson University
- Developer University of Tokyo
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer